Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine

Addiction

Volumn 107, Issue SUPPL.1, 2012, Pages 83-90

  Holbrook, Amber M ^a   Baxter, Jason K ^a   Jones, Hendrée E ^b,c   Heil, Sarah H ^d,e   Coyle, Mara G ^f   Martin, Peter R ^g   Stine, Susan M ^h   Kaltenbach, Karol ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f BROWN UNIVERSITY   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

Author keywords

Buprenorphine; Medical infections; Methadone; Obstetrical outcomes; Pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; BUPRENORPHINE; COMMUNICABLE DISEASES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; LOGISTIC MODELS; METHADONE; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; YOUNG ADULT;

EID: 84868135410     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04042.x     Document Type: Article

References (34)

1. Abraham H., Degli-Esposti S., Marino L. Seroprevalence of hepatitis C in a sample of middle class substance abusers. J Addict Dis 1999; 18: 77-87.
2. Rosenblum A., Nuttbrock L., McQuistion H. L., Mugaru S., Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis 2001; 20: 15-25.
3. Thorpe L. E., Ouellet L. J., Hershow R., Bailey S. L., Williams I. T., Williamson J. etal. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002; 155: 645-653.
4. Bouza E., Menasalvas A., Munoz P., Vasallo F. J., del Mar Moreno M., Garcia Fernandez M. A. Infective endocarditis: a prospective study at the end of the twentieth century-new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Balt) 2001; 80: 298-307.
5. Dressler F. A., Roberts W. C. Infective endocarditis in opiate addicts: analysis of 80 cases studied at necropsy. Am J Cardiol 1989; 63: 1240-1257.
6. Hecht S., Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992; 117: 560-566.
7. Wilson L. E., Thomas D. L., Astemborski J., Freedman T. L., Vlahov D. Prospective study of infective endocarditis among injection drug users. J Infect Dis 2002; 185: 1761-1766.
8. Cherubin C. E. Infectious disease problems of narcotic addicts. Arch Intern Med 1971; 128: 309-313.
9. Centers for Disease Control and Prevention. Tetanus among injecting-drug users-California, 1997. Morb Mortal Wkly Rep 1998; 47: 149-151.
10. Naye R. L., Blanc W., LeBlanc W., Khatanee M. A. Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. J Pediatr 1973; 83: 1055-1061.
11. Binswanger I. A., Kral A. H., Bluthenthal R. N., Rybold D. J., Edlin B. R. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000; 30: 579-581.
12. Blinick G., Wallach R. C., Jerez E. Pregnancy in narcotic addicts treated by medical withdrawal. The methadone detoxification program. Am J Obstet Gynecol 1969; 105: 997-1003.
13. Cherubin C. E., Millian S. J. Serologic investigations in narcotic addicts. I. Syphylis, lymphogranuloma venereum, herpes simplex, and Q fever. Ann Intern Med 1968; 69: 739-742.
14. Finnegan L. P. Pathophysiological and behavioual effects of the transplacental transfer of narcotic drugs to the fetuses and neonates of narcotic-dependent mothers. Bull Narc 1979; 31: 1-58.
15. Pinto S. M., Dodd S., Walkinshaw S. A., Siney C., Kakkar P., Mousa H. A. Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 150: 137-141.
16. Hulse G. K., Milne E., English D. R., Holman C. D. J. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571-1579.
17. Fajemirokun-Odudeyi O., Sinha C., Tutty S., Pairaudeau P., Armstrong D., Phillips T. etal. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol 2006; 126: 170-175.
18. Ludlow J. P., Evans S. F., Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust NZ J Obstet Gynaecol 2004; 44: 302-306.
19. Alroomi L. G., Davidson J., Evans T. J., Galea P., Howat R. Maternal narcotic abuse and the newborn. Arch Dis Child 1988; 6: 81-83.
20. Messinger D. S., Bauer C. R., Das A., Seifer R., Lester B. M., Lagasse L. L. etal. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004; 113: 1677-1685.
21. Bakstad B., Monica S., Welle-Strand G. K., Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. Eur Addict Res 2009; 15: 128-134.
22. Kakko J., Heilig M., Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008; 96: 69-78.
23. Lejeune C., Simmat-Durand L., Gourarier L., Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 2006; 82: 250-257.
24. Fischer G., Ortner R., Rohrmeister K., Jagsch R., Baewert A., Langer M. etal. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006; 101: 275-281.
25. Jones H. E., Johnson R. E., Jasinski D. R., O'Grady K. E., Chisholm C. A., Choo R. E. etal. Buprenorphine versus methadone in the treatment of pregnant opioid dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79: 1-10.
26. Jones H. E., Kaltenbach K., Heil S. H., Stine S. M., Coyle M., Arria A. M. etal. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
27. Jones H. E., Fischer G., Heil S. H., Kaltenbach K., Martin P. R., Coyle M. G. etal. Maternal Opioid Treatment: Human Experimental Research (MOTHER)-approach, issues and lessons learned. Addiction 2012; 107 (Suppl. 1): 28-35.
28. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. etal. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.
29. Kawakami N., Takatsuka N., Inaba S., Shimizu H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav 1999; 24: 155-166.
30. McNicholas L., Holbrook A. M., O'Grady K. E., Jones H. E., Coyle M. G., Martin P. R. etal. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on agonist medication. Addiction 2012; 107 (Suppl. 1): 91-97.
31. Moss R., Munt B. Injection drug use and right sided endocarditis. Heart 2003; 89: 577-581.
32. Semaan S., Sternberg M., Zaidi A., Aral S. O. Social capital and rates of gonorrhea and syphilis in the United States: spatial regression analyses of state-level associations. Soc Sci Med 2007; 64: 2324-2341.
33. Almario C. V., Seligman N. S., Dysart K. C., Berghella V., Baxter J. K. Risk factors for preterm birth among opioid-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol 2009; 201: 326.e1-3266.
34. Binder T., Vavrinkova B. Prospective randomized comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett 2008; 29: 80-86.